A new study published in Nature Communications Medicine led by neurosurgery researchers Sima Mofakham, PhD, and Chuck Mikell, MD, of the Renaissance School of Medicine (RSOM) at Stony Brook University ...

Researchers developed a new PET tracer capable of measuring synapse loss after spinal cord injury, offering insights into both spinal and brain changes.

Former basketball player Jason Collins, who retired from the NBA in 2014, is undergoing treatment for a brain tumor, his family shared in a statement.

Dino Morea, me and Gaurav Kapur, were all inside the car,” said Tanishaa, recalling the moment the accident took place ...

Ibogaine is a Schedule 1 drug in America with no legal medical uses. But the results, several athletes say, are game-changing ...

UCLA's researchers go low-tech to plead their case to the public with poster boards and props. The Trump administration has ...

Use of MLC901 after mild TBI results in significant improvements in some clinical outcomes, though it does not improve cognitive impairment.

In 2018 the National Institute of Neurological Disorders and Stroke (NINDS) awarded a five-year, $2.9 million R01 grant to a ...

Some anti-drug campaigns work, while others are memorable but don't succeed in making people give up smoking or other ...

As you age, your risk of this type of brain injury goes up. That’s why it’s important to know the signs and the best ways to ...

Patients with traumatic brain injury (TBI) have higher health care utilization and health needs across health care settings, according to research published in The Journal of Head Trauma ...

Ibogaine, a psychoactive indole alkaloid derived from the root bark of the African shrub Tabernanthe iboga, has emerged as a potential therapeutic agent for TBI.